The Nigerian Centre for Disease Control (NCDC) has confirmed 157 cases of monkeypox from 1 January to 31 July, 2022, across the country, with a total of four deaths recorded from four states.
The health agency made the disclosure from its update for the Epi Week 30 report, with 24 new cases of the infection, totally 154 confirmed cases altogether, of the 413 suspected cases for the period in view.
According to the report, the four states with case mortality are Delta (1), Lagos (1), Ondo (1) and Akwa-Ibom (1).
NCDC also revealed that enhanced surveillance at the national and subnational levels with improved case detection and reporting as well as the recent attention from the global outbreak has contributed in part or whole to the observed increase in cases observed in the country.
According to the new report by the agency, there were fifty-six (56) new suspected cases reported in Epi week 30, 2022 (25th to 31st July 2022) from nineteen (19) states:
Ondo (13), Plateau (8), Lagos (6), Adamawa (4), Abia (3), Borno (3), Delta (2), Kano (3), Anambra (2), Bayelsa (2), Kwara (2), Akwa Ibom (1), Gombe (1), Imo (1), Nasarawa (1), Osun (1), Oyo (1), Rivers (1), and Taraba (1).
Of fifty-six (56) suspected cases, there were twenty-four (24) new confirmed positive cases in Epi week 30, 2022 from twelve (12) states:
Ondo (5), Kano (3), Lagos (3), Abia (2), Adamawa (2), Bayelsa (2), Kwara (2), Delta (1), Anambra (1), Gombe (1), Rivers (1), Nasarawa (1).
In addition to testing for the monkeypox virus, the agency also released different case definitions. These are:
• Suspected case
An acute illness with fever >38.3oC, intense headache, lymphadenopathy, back pain, myalgia, and intense asthenia followed one to three days later by a progressively developing rash often beginning on the face (most dense) and then spreading elsewhere on the body, including soles of feet and palms of the hand.
• Probable case
A case that meets the clinical case definition is not laboratory-confirmed but has an epidemiological link to a confirmed case.
• Confirmed case
A clinically compatible case that is laboratory confirmed
Any person who has been in direct or indirect contact with a confirmed case since the onset of symptoms, i.e., contact with skin lesions, oral secretions, urine, faeces, vomitus, blood, sexual contact, sharing a common space (anyone who has been in proximity with or without physical contact with a confirmed case.